MedPath

Evaluation of intravenous Propofol and Midazolam on sedation during spinal anesthesia in cesarean sectio

Phase 2
Recruiting
Conditions
T88.52
sedation and nausea & vomiting during spinal anesthesia in cesarean section.
Failed moderate sedation during procedure
Registration Number
IRCT20120915010841N21
Lead Sponsor
Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
102
Inclusion Criteria

18-45 aged pregnant women for C/S
ASA CLASS 1, 2
Satisfaction to participate in the project
Pregnant women who underwent cesarean section under spinal anesthesia

Exclusion Criteria

sensitivity to medications used
Patients who have failed spinal anesthesia and undergo general anesthesia
Lung disease, heart disease, asthma, fever, hypertension, preeclampsia and eclampsia, cardiac arrhythmia
Emergency Cesarean
Eclampsia and Preeclampsia
Multiple pregnancy
Spinal anesthesia contraindications (high ICP, hypovolemia, anemia, coagulation disorders, etc.)
History of allergy to eggs, soy, midazolam and propofol
Use of antiemetic drugs

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sedation. Timepoint: We record ramsy sedation score in 24 hours after surgery.?. Method of measurement: Ramsy sedation score.;Nausea & vomiting. Timepoint: After surgery. Method of measurement: Observation.
Secondary Outcome Measures
NameTimeMethod
Systolic and Diastolic Blood Pressure. Timepoint: Every 5 minutes (from drug administration until end of surgery). Method of measurement: Non-invasive automatic barometric device.;Heart Rate. Timepoint: Every 5 minutes (from drug administration until end of surgery). Method of measurement: Using a pulse oximeter.
© Copyright 2025. All Rights Reserved by MedPath